Publications by authors named "Sally Barbour"

Claim this Profile
W
Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network.
Jennifer P Booth, Julie M Kennerly-Shah, Lindsey R Kelley, Donna Capozzi, Hillary A Prescott, Sally Y Barbour

J Oncol Pharm Pract· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adapting to Change: A Thoracic Oncology Team's Perspective.
Jeffrey Crawford, Susan Blackwell, Sally Yowell Barbour

JCO Oncol Pract· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value Assessment of Oncology Pharmacist Interventions.
Mallika P Patel, Sally Y Barbour, Meredith T Moorman

J Adv Pract Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Role and Impact of Ambulatory Clinical Pharmacists in an Academic Comprehensive Cancer Center.
Laura A Meleis, Mallika P Patel, Michael DeCoske, Meredith Moorman, Paul W Bush, Sally Barbour

J Adv Pract Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiemetics: ASCO Guideline Update.
Paul J Hesketh, Mark G Kris, Ethan Basch, Kari Bohlke, Sally Y Barbour

J Clin Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2018-2019 Drug Updates in Solid Tumors.
Sally Barbour

J Adv Pract Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of skeletal related events in patients with bone metastasis receiving denosumab every four weeks compared to intervals greater than every four weeks.
Prakirthi Yerram, Russell Moore, Steven Wolf, Sally Y Barbour

J Oncol Pharm Pract· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.
Paul J Hesketh, Mark G Kris, Ethan Basch, Kari Bohlke, Sally Y Barbour

J Clin Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines Insights: Antiemesis, Version 2.2017.
Michael J Berger, David S Ettinger, Jonathan Aston, Sally Barbour, Jason Bergsbaken

J Natl Compr Canc Netw· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Patients With Chemotherapy-Induced Nausea and Vomiting.
Sally Yowell Barbour

J Adv Pract Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Board-Certified Oncology Pharmacists: Their Potential Contribution to Reducing a Shortfall in Oncology Patient Visits.
Robert Ignoffo, Katherine Knapp, Mitchell Barnett, Sally Yowell Barbour, Steve D'Amato

J Oncol Pract· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of eribulin mesylate in patients with pretreated metastatic breast cancer.
Susan Goodin, Sally Barbour, James Song, Erhan Berrak, David Cox

Am J Health Syst Pharm· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palonosetron versus older 5-HT3 receptor antagonists for nausea prevention in patients receiving chemotherapy: a multistudy analysis.
Gary R Morrow, Lee Schwartzberg, Sally Y Barbour, Gianluca Ballinari, Michael D Thorn

J Community Support Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV).
Lee Schwartzberg, Sally Y Barbour, Gary R Morrow, Gianluca Ballinari, Michael D Thorn

Support Care Cancer· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiemesis.
David S Ettinger, Debra K Armstrong, Sally Barbour, Michael J Berger, Philip J Bierman

J Natl Compr Canc Netw· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corticosteroids in the treatment of chemotherapy-induced nausea and vomiting.
Sally Yowell Barbour

J Natl Compr Canc Netw· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American College of Chest Physicians consensus statement on the use of topical anesthesia, analgesia, and sedation during flexible bronchoscopy in adult patients.
Momen M Wahidi, Prasoon Jain, Michael Jantz, Pyng Lee, G Burkhard Mackensen, Sally Y Barbour

Chest· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of oncology clinical pharmacists in light of the oncology workforce study.
Jolynn K Sessions, John Valgus, Sally Yowell Barbour, Lew Iacovelli

J Oncol Pract· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality management of potential chemotherapy-induced neutropenic complications: evaluation of practice in an academic medical center.
Amy P Abernethy, Sally Y Barbour, Hope Uronis, S Yousuf Zafar, April Coan

Support Care Cancer· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiemesis. Clinical Practice Guidelines in Oncology.
David S Ettinger, Debra K Armstrong, Sally Barbour, Michael J Berger, Philip J Bierman

J Natl Compr Canc Netw· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caring for the treatment-experienced breast cancer patient: the pharmacist's role.
Sally Yowell Barbour

Am J Health Syst Pharm· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of carboplatin/vinorelbine with pegfilgrastim support for the treatment of patients with advanced non-small cell lung cancer.
Richard F Riedel, Carolyn Andrews, Jennifer Garst, Frank Dunphy, James E Herndon, Sally Barbour

J Thorac Oncol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis